Insilico's Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too

Insilico's Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too

来源:WSJ发布于 2026-09-07

Alex Zhavoronkov, founder and co-chief executive of techbio company Insilico, is among the scientists who have devoted countless hours to studying aging.

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。